ConverGene LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:ConverGene LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10952
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ConverGene LLC (ConverGene) is a small molecule discovery company that offers development of cancer drugs targeting the root regulatory mechanisms within cancer cells. The company develops small-molecule drugs that aim at bromodomains, a structural feature of proteins, which mediate epigenetic changes in deoxyribose nucleic acid and packaging proteins. ConverGene’s portfolio includes candidates for the treatment for solid and liquid tumours, and neurological psychiatric disorders. It develops compounds to treat two types of malignancies with orphan disease status, acute myelogenous leukemia and multiple myeloma, among others. The company works in partnership with universities, research institutes and drug development companies. ConverGene is headquartered in Cambridge, Maryland, the US.

ConverGene LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ConverGene LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ConverGene LLC, Medical Devices Deals, 2012 to YTD 2018 9
ConverGene LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ConverGene LLC, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
ConverGene Raises USD0.85 Million in Venture Financing 11
Partnerships 12
ConverGene Enters into Research Agreement with MD Anderson Cancer Center 12
ConverGene Enters into Development Agreement with National Institute of Neurological Disorders and Stroke 13
ConverGene Enters into Research Agreement with University of Maryland School of Medicine 14
Licensing Agreements 15
ConverGene Enters into Licensing Agreement with National Center for Advancing Translational Sciences 15
ConverGene LLC – Key Competitors 16
ConverGene LLC – Key Employees 17
ConverGene LLC – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
ConverGene LLC, Pharmaceuticals & Healthcare, Key Facts 2
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ConverGene LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ConverGene LLC, Deals By Therapy Area, 2012 to YTD 2018 8
ConverGene LLC, Medical Devices Deals, 2012 to YTD 2018 9
ConverGene LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ConverGene Raises USD0.85 Million in Venture Financing 11
ConverGene Enters into Research Agreement with MD Anderson Cancer Center 12
ConverGene Enters into Development Agreement with National Institute of Neurological Disorders and Stroke 13
ConverGene Enters into Research Agreement with University of Maryland School of Medicine 14
ConverGene Enters into Licensing Agreement with National Center for Advancing Translational Sciences 15
ConverGene LLC, Key Competitors 16
ConverGene LLC, Key Employees 17

List of Figures
ConverGene LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ConverGene LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ConverGene LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ConverGene LLC, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[ConverGene LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Snyder’s-Lance, Inc.:戦略・SWOT・企業財務分析
    Snyder's-Lance, Inc. - Strategy, SWOT and Corporate Finance Report Summary Snyder's-Lance, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Airbus SAS:戦略・SWOT・企業財務分析
    Airbus SAS - Strategy, SWOT and Corporate Finance Report Summary Airbus SAS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Baumot Group AG (TINC):企業の財務・戦略的SWOT分析
    Baumot Group AG (TINC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • New Age Metals Inc:企業の戦略・SWOT・財務情報
    New Age Metals Inc - Strategy, SWOT and Corporate Finance Report Summary New Age Metals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Iberdrola SA (IBE):企業の財務・戦略的SWOT分析
    Iberdrola SA (IBE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Arsanis Inc (ASNS):製薬・医療:M&Aディール及び事業提携情報
    Summary Arsanis Inc (Arsanis) is a clinical-stage biopharmaceutical company that focuses on the development of monoclonal antibody immunotherapies for the treatment of critical infectious diseases. The company’s pipeline product portfolio includes ASN100, for staphylococcus aureus; ASN500, targets r …
  • Takeuchi Mfg. Co Ltd:企業の戦略・SWOT・財務分析
    Takeuchi Mfg. Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Takeuchi Mfg. Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Electrical Geodesics Inc:企業の製品パイプライン分析2018
    Summary Electrical Geodesics Inc (EGI) is a medical device company that designs, develops and commercializes non-invasive neuro diagnostic products used to monitor and interpret brain activity. The company offers clinical products such as geodesic EEG system 400 series, spike detection software, geo …
  • Somnomed Ltd (SOM):医療機器:M&Aディール及び事業提携情報
    Summary Somnomed Ltd (SomnoMed) is a medical device company that develops, produces, commercializes and markets devices for the oral treatment of sleep-related disorders. The company’s products include Somnodent, an oral appliance for obstructive sleep apnea; and Somnobrux, a mouthguard that protect …
  • Tauron Polska Energia SA:企業の発電所・SWOT分析2018
    Tauron Polska Energia SA - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Royal Mail plc:企業の戦略・SWOT・財務情報
    Royal Mail plc - Strategy, SWOT and Corporate Finance Report Summary Royal Mail plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Cellumed Co Ltd (049180)-医療機器分野:企業M&A・提携分析
    Summary Cellumed Co Ltd (Cellumed), formerly Korea Bone Bank Inc, is a biotechnology company that develops bone graft substitution based on human tissue graft. The company’s portfolio encompasses spinal fixation systems; joint replacement and navigation system; bone powder; DBM gel; bio-clearant, an …
  • Toleranzia AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Toleranzia AB (Toleranzia) is a drug developer that utilizes immune system’s intrinsic power to treat autoimmune diseases. The company offers products and technologies including Re-Tolerogen for the treatment of autoimmune diseases. Its Re-Tolerogen platform technology is a fusion protein fo …
  • LPP SA (LPP):企業の財務・戦略的SWOT分析
    LPP SA (LPP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Gammon Infrastructure Projects Ltd (GAMMNINFRA)-エネルギー分野:企業M&A・提携分析
    Summary Gammon Infrastructure Projects Limited (GIPL) is an infrastructure project development company. It undertakes projects on a public private partnership basis (PPP) across various sectors including hydro power, roads and expressways, ports, urban infrastructure, airports, special economic zone …
  • DermTech Inc:医療機器:M&Aディール及び事業提携情報
    Summary DermTech Inc (DermTech) is a dermatology company that develops non-invasive gene expression tests to facilitate the early detection of skin cancers, assess inflammatory diseases, and customize drug treatments. The company’s products include adhesive skin sample collection kit, that allows co …
  • Instituto Costarricense de Electricidad:企業の戦略的SWOT分析
    Instituto Costarricense de Electricidad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Premier Oil plc:企業の戦略・SWOT・財務分析
    Premier Oil plc - Strategy, SWOT and Corporate Finance Report Summary Premier Oil plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Absher Construction Company:企業の戦略・SWOT・財務情報
    Absher Construction Company - Strategy, SWOT and Corporate Finance Report Summary Absher Construction Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Zeltiq Aesthetics Inc (ZLTQ)-医療機器分野:企業M&A・提携分析
    Summary Zeltiq Aesthetics Inc (Zeltiq), a subsidiary of Allergan Plc is a medical technology company that develops and commercializes products of cooling technology. The company offers CoolSculpting System utilizing proprietary controlled-cooling technology to selectively reduce stubborn fat bulges. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆